Appendices

Fiscal Year 2021 Financial Summary

Statement of Net Position as of June 30, 2021

Current assets
Current assets	$61,329,960
Noncurrent assets	$1,664,204
Capital assets	$51,230
Total assets	$63,045,395

Liabilities:
Current liabilities	$32,511,373
Noncurrent liabilities	$84,500
Total liabilities	$32,595,873

Net position:
Net investment in capital assets	$51,230
Unrestricted	$30,398,292
Total net position	$30,449,522
Total liabilities and net position	$63,045,395

Statements of Revenues, Expenses and Changes in Net Position
July 1, 2020 - June 30, 2021

Revenues and expenses:
Operating revenues	$55,561,452
Operating expenses	$(62,867,496)
Operating loss	$(7,306,044)

Nonoperating revenues	$126,737
Capital contributions	-
Increase (decrease) in net position	$(7,179,306)

^{The complete audited statements are available on the Massachusetts Life Sciences Center website or you can request a copy by calling 781-373-7777 or emailing.}

Fiscal Year 2021 Investments: Awards and Programs Approved by the MLSC Board of Directors

Month/year	Awards	Program	Headquarters/Work Performed	Total
Sep-20	Tekkware, Inc.	COVID-19 Response	Gloucester	$ 209,840
Sep-20	High Purity Natural Products, LLC	COVID-19 Response	Southbridge	$ 52,500
Sep-20	Heritage Hemp, LLC	COVID-19 Response	Northampton	$ 63,352
Sep-20	Industrial Polymers and Chemicals, Inc.	COVID-19 Response	Shrewsbury	$ 150,000
Sep-20	Web Industries, Inc.	COVID-19 Response	Marlborough	$2,524,308
Sep-20	Randolph Public Schools	STEM Equipment and Professional Development	Randolph	$ 137,173
Sep-20	Mass Insight Education & Research	CEO Discretionary	Boston	$ 27,948
Oct-20	United Negro College Fund	CEO Discretionary	Boston	$ 50,000
Oct-20	EnVision Endoscopy, Inc.	Seed Fund	Lowell	$ 250,000
Dec-20	FY21-22 Internship Program	Internship Challenge	Various - Statewide	$ 2,500,000
Dec-20	2021 High School Apprenticeship Program	High School Apprenticeship	Various - Statewide	$ 500,000
Dec-20	Haystack Diagnostics, Inc.	Seed Fund	Lowell	$ 250,000
Feb-21	Decoy Therapeutics, Inc.	Seed Fund	Lowell	$ 250,000
Feb-21	Beth Israel Deaconess Medical Center	Research Infrastructure Program	Boston	$ 3,307,757
Feb-21	Dana-Farber Cancer Institute, Inc.	Research Infrastructure Program	Boston	$ 1,824,028
Feb-21	Museum of Science	Research Infrastructure Program	Boston	$ 1,520,760
Feb-21	Tufts University	Research Infrastructure Program	North Grafton	$ 2,027,244
Feb-21	UMass Chan Medical School	Research Infrastructure Program	Worcester	$ 2,797,610
Feb-21	FY21 Angel Investors	Angel Investor Tax Credit	Various - Statewide	$ 474,303
Feb-21	AcousticaBio (2021 M2D2 $200K Challenge)	Innovation Challenge	Somerville	$ 50,000
Mar-21	Life Science Cares	CEO Discretionary	Cambridge	$ 25,000
Apr-21	Massachusetts Biotechnology Education Foundation	CEO Discretionary	Cambridge	$ 50,000
Apr-21	Abiomed, Inc.	Tax Incentive Program	Danvers	$ 675,000
Apr-21	Alloy Therapeutics, Inc.	Tax Incentive Program	Lexington	$ 150,000
Apr-21	Allurion Technologies	Tax Incentive Program	Natick	$ 150,000
Apr-21	Alnylam Pharmaceuticals, Inc.	Tax Incentive Program	Norton	$ 1,950,000
Apr-21	Berkshire Sterile Manufacturing	Tax Incentive Program	Lee	$ 185,000
Apr-21	CONTINUUS Pharmaceuticals	Tax Incentive Program	Woburn	$ 375,000
Apr-21	CRISPR Therapeutics, Inc.	Tax Incentive Program	Framingham	$ 1,065,000
Apr-21	EMD Holding Corporation	Tax Incentive Program	Danvers	$ 1,725,000
Apr-21	Finch Therapeutics, Inc.	Tax Incentive Program	Somerville	$ 750,000
Apr-21	FUJIFILM Holdings America Corporation	Tax Incentive Program	Watertown	$ 195,000
Apr-21	Global Life Science Solutions USA LLC	Tax Incentive Program	Westborough	$ 1,950,000
Apr-21	Instrumentation Laboratory Company	Tax Incentive Program	Bedford	$ 255,000
Apr-21	Insulet Corporation	Tax Incentive Program	Acton	$ 3,100,000
Apr-21	Invagen Pharmaceuticals, Inc.	Tax Incentive Program	Fall River	$ 150,000
Apr-21	Lyndra Therapeutics, Inc.	Tax Incentive Program	Watertown	$ 495,000
Apr-21	Masy Systems, Inc.	Tax Incentive Program	Pepperell	$ 300,000
Apr-21	ModernaTX, Inc.	Tax Incentive Program	Norwood	$ 2,325,000
Apr-21	Mustang Bio, Inc.	Tax Incentive Program	Worcester	$ 300,000
Apr-21	NanoDx, Inc.	Tax Incentive Program	Southborough	$ 180,000
Apr-21	Oncorus, Inc.	Tax Incentive Program	Andover	$ 375,000
Apr-21	OpenClinica, LLC	Tax Incentive Program	Waltham	$ 150,000
Apr-21	Proof Diagnostics, Inc. (formerly Pine Trees Health, Inc.)	Tax Incentive Program	Cambridge	$ 150,000
Apr-21	Snapdragon Chemistry, Inc.	Tax Incentive Program	Waltham	$ 150,000
Apr-21	SQZ Biotech	Tax Incentive Program	Watertown	$ 375,000
Apr-21	Stoke Therapeutics, Inc.	Tax Incentive Program	Bedford	$ 300,000
Apr-21	Verve Therapeutics, Inc.	Tax Incentive Program	Boston	$ 525,000
Apr-21	ZOLL Medical Corporation	Tax Incentive Program	Chelmsford	$ 675,000
Apr-21	Adaptilens, LLC	MassNextGen	Chestnut Hill	$ 87,500
Apr-21	AOA Dx, Inc.	MassNextGen	Cambridge	$ 87,500
Apr-21	InnoTech	MassNextGen	Lowell	$ 87,500
Apr-21	Power of Patients	MassNextGen	Boston	$ 87,500
Apr-21	Reboot Rx	MassNextGen	Winchester	$ 87,500
Apr-21	UMass Medical School, Baystate Medical Center: Dr. Sallie Schneider	First Look Award	Boston, Springfield	$ 50,000
Apr-21	Beth Israel Deaconess Medical Center	Bits to Bytes	Boston	$ 750,000
Apr-21	Brigham and Women's Hospital	Bits to Bytes	Boston	$ 749,498
Apr-21	Harvard T.H. Chan School of Public Health	Bits to Bytes	Boston	$ 737,950
Apr-21	Boston Children’s Hospital	Bits to Bytes	Boston	$ 749,950
Apr-21	Institute for Protein Innovation	Bits to Bytes	Boston	$ 750,000
Apr-21	Tufts University	Bits to Bytes	Medford	$ 750,000
Apr-21	Northeastern University	Novel Therapeutics Delivery	Boston	$ 749,858
Apr-21	Tufts University	Novel Therapeutics Delivery	Boston	$ 745,403
Apr-21	Boston Children’s Hospital	Novel Therapeutics Delivery	Boston	$ 548,571
Apr-21	Harvard Medical School Department of Systems Biology	Women's Health	Boston	$ 750,000
Apr-21	Dana-Farber Cancer Institute, Inc.	Women's Health	Boston	$ 748,075
Apr-21	Massachusetts Institute of Technology	Women's Health	Boston	$ 665,000
Apr-21	Tufts University	Women's Health	Boston	$ 251,548
Apr-21	UMass Lowell	NIIMBL	Lowell	$ 216,090
Apr-21	Northeastern University	NIIMBL	Boston	$ 375,000
Apr-21	Massachusetts Institute of Technology	NIIMBL	Boston	$ 266,850
May-21	MassMEDIC Ignite	CEO Discretionary	Boston	$ 25,000
Jun-21	New England Biolabs, Inc.	Tax Incentive Program	Ipswich	$ 525,000
Jun-21	Beth Israel Deaconess Medical Center	Women's Health Innovation Grant	Boston	$ 209,497
Jun-21	Boston Medical Center	Women's Health Innovation Grant	Boston	$ 292,716
Jun-21	Boston University	Women's Health Innovation Grant	Boston	$ 300,000
Jun-21	Dana-Farber Cancer Institute, Inc.	Women's Health Innovation Grant	Boston	$ 300,000
Jun-21	Dana-Farber Cancer Institute, Inc.	Women's Health Innovation Grant	Boston	$ 299,999
Jun-21	Massachusetts General Hospital	Women's Health Innovation Grant	Boston	$ 300,000
Jun-21	Massachusetts General Hospital	Women's Health Innovation Grant	Boston	$ 297,993
Jun-21	Massachusetts Institute of Technology	Women's Health Innovation Grant	Boston	$ 295,621
Jun-21	UMass Amherst	Women's Health Innovation Grant	Hadley	$ 290,215
Jun-21	Worcester Polytechnic Institute	Women's Health Innovation Grant	Worcester	$ 237,542
Jun-21	Abby Kelley Foster CPS	STEM Equipment and Professional Development	Worcester	$ 84,139
Jun-21	Boston Public Schools	STEM Equipment and Professional Development	Boston	$ 108,487
Jun-21	Bristol-Plymouth RTS	STEM Equipment and Professional Development	Taunton	$ 95,683
Jun-21	Brockton Public Schools	STEM Equipment and Professional Development	Brockton	$ 77,362
Jun-21	Dracut High School	STEM Equipment and Professional Development	Dracut	$ 63,541
Jun-21	Essex North Shore Agricultural and Technical District	STEM Equipment and Professional Development	Danvers	$ 119,300
Jun-21	Everett Public Schools	STEM Equipment and Professional Development	Everett	$ 90,976
Jun-21	Fall River Public Schools	STEM Equipment and Professional Development	Fall River	$ 176,429
Jun-21	Foxborough Regional Charter School	STEM Equipment and Professional Development	Foxborough	$ 46,086
Jun-21	Greater New Bedford Regional Vocational Technical High School	STEM Equipment and Professional Development	New Bedford	$ 51,533
Jun-21	Haverhill Public Schools	STEM Equipment and Professional Development	Haverhill	$ 62,715
Jun-21	Holyoke Public Schools	STEM Equipment and Professional Development	Holyoke	$ 189,533
Jun-21	i2 Learning Foundation, Inc.	STEM Equipment and Professional Development	Boston	$ 146,641
Jun-21	Leominster Public Schools	STEM Equipment and Professional Development	Leominster	$ 226,851
Jun-21	Massachusetts Biotechnology Education Foundation	STEM Equipment and Professional Development	Cambridge	$ 168,039
Jun-21	Montachusett Regional Vocational Technical School	STEM Equipment and Professional Development	Fitchburg	$ 109,988
Jun-21	New Bedford Public Schools	STEM Equipment and Professional Development	New Bedford	$ 240,000
Jun-21	Pathfinder Regional Vocational Technical High School	STEM Equipment and Professional Development	Palmer	$ 44,931
Jun-21	Project Lead The Way	STEM Equipment and Professional Development	Various - Statewide	$ 235,306
Jun-21	Prospect Hill Academy Charter School	STEM Equipment and Professional Development	Cambridge	$ 50,000
Jun-21	Quaboag Regional School District	STEM Equipment and Professional Development	Warren	$ 101,069
Jun-21	Quincy Public School	STEM Equipment and Professional Development	Quincy	$ 224,839
Jun-21	Rockland Public Schools	STEM Equipment and Professional Development	Rockland	$ 189,131
Jun-21	South Shore Vocational Technical High School	STEM Equipment and Professional Development	Hanover	$ 94,131
Jun-21	Westfield Public Schools	STEM Equipment and Professional Development	Westfield	$ 194,742
Jun-21	Whittier Regional Vocational Technical High School	STEM Equipment and Professional Development	Haverhill	$ 20,000
Jun-21	Worcester Public Schools	STEM Equipment and Professional Development	Worcester	$ 188,548
Jun-21	Leukocare	MassTAG	Milford	$ 165,000
Jun-21	The Base, Inc.	CEO Discretionary	Roxbury	$ 50,000
Jun-21	Gloucester Marine Genomics Institute	CEO Discretionary	Gloucester	$ 35,000
Jun-21	BioBuilder	CEO Discretionary	Newton	$ 50,000
			Total	$ 55,381,699

_{^{MassNextGen is also supported by funds from Takeda, King Street Properties, Sanofi Genzyme, and Johnson & Johnson.}}

Certified Life Sciences Companies

List of Certified Active Life Sciences Companies as of June 30, 2021

Company	Location
149 Medical, Inc.	Worcester
Abiomed, Inc.	Danvers
AcousticaBio	Somerville
Adaptilens, LLC	Chestnut Hill
Alkermes, Inc.	Waltham
Alloy Therapeutics Inc.	Lexington
Allurion Technologies	Natick
Alnylam Pharmaceuticals, Inc.	Cambridge
Amplyus	Cambridge
Amsel Medical	Cambridge
Anodyne Nanotech, Inc.	Medford
Antagen Diagnostics	Boston
AOA Dx, Inc.	Cambridge
Astellas Institute for Regenerative Medicine	Marlborough
AXONIS Therapeutics, Inc.	Cambridge
Beam Therapeutics, Inc.	Cambridge
Berkshire Sterile Manufacturing	Lee
Bio2 Technologies, Inc.	Woburn
BioDevek, Inc.	Cambridge
Blueprint Medicines Corporation	Cambridge
Boston Cell Standards, Inc.	Boston
Cellino Biotech, Inc.	Cambridge
Charles River Laboratories, Inc.	Wilmington
Charm Sciences, Inc.	Lawrence
Commonwealth Diagnostics International, Inc.	Salem
Concerto Biosciences, Inc.	Allston
CONTINUUS Pharmaceuticals	Woburn
CRISPR Therapeutics, Inc.	Cambridge
Cx Therapeutics, Inc.	Lexington
Dassault Systemes	Waltham
Day Zero Diagnostics, Inc.	Allston
Decoy Therapeutics, Inc.	Lowell
Dicerna Pharmaceuticals, Inc.	Cambridge
DxLab, Inc.	Somerville
eGenesis, Inc.	Cambridge
EMD Holding Corporation	Burlington
Enanta Pharmacuticals, Inc.	Watertown
Envision Endoscopy	Somerville
Ernest Pharmaceuticals, LLC	Hadley
Evelo Biosciences, Inc.	Cambridge
Excellims Corporation	Acton
Finch Therapeutics, Inc.	Somerville
Folia Health, Inc.	Cambridge
Freudenberg Medical, LLC	Gloucester
FUJIFILM Holdings America Corporation	Watertown
Fulcrum Therapeutics, Inc.	Cambridge
Gel4Med, Inc.	Lowell
Gelmedix, Inc.	Newton
Ginkgo Bioworks, Inc.	Boston
Global Life Science Solutions USA LLC	Westborough
Gritstone Oncology, Inc.	Cambridge
Haystack Diagnostics, Inc.	Lowell
Hepatochem, Inc.	Beverly
Heritage Hemp	Northampton
Hilltop BioSciences, Inc.	Mansfield
Homology Medicines, Inc.	Bedford
Indigo Agriculture, Inc.	Boston
InnoTech	Lowell
Inozyme Pharma, Inc.	Boston
Instrumentation Laboratory Company	Bedford
Insulet Corporation	Acton
Intellia Therapeutics	Cambridge
Intera Oncology, Inc.	Wellesley Hills
Invagen Pharmaceuticals Inc.	Fall River
Ipsen Biopharmaceuticals, Inc.	Cambridge
iVexSol, Inc.	Worcester
Kala Pharmaceuticals, Inc.	Waltham
KnipBio	Lowell
Kymera Therapeutics, Inc.	Cambridge
Kytopen Corp.	Cambridge
LaunchPad Medical, Inc.	Lowell
Leukocare	Milford
LivOnyx, Inc.	Allston
Lucy Therapeutics, Inc.	Reading
Lykan Bioscience, LLC	Hopkinton
Lyndra Therapeutics, Inc.	Watertown
Masy Systems, Inc.	Pepperell
Medidata Solutions, Inc. & SHYFT Analytics, Inc.	Boston
Mevion Medical Systems, Inc.	Littleton
MindMics, Inc.	Cambridge
MitoLab, Inc.	Allston
Moderna Therapeutics, Inc.	Cambridge
Morphic Therapeutic, Inc.	Waltham
Mustang Bio, Inc.	Worcester
NanoDx, Inc.	Southborough
New England Biolabs, Inc.	Ipswich
New Equilibrium Biosciences, Inc.	Boston
New View Surgical, Inc.	Boston
Northway Biotech, Inc.	Waltham
Nova Biomedical Corporation	Waltham
nQ Medical	Cambridge
Nutrimedy, Inc.	Worcester
Oncorus, Inc.	Andover
OpenClinica, LLC	Waltham
PhagePro, Inc.	Somerville
PhAST Corp.	Cambridge
PionEar Technologies, Inc.	Allston
Platelet Biogenesis, Inc.	Cambridge
Power of Patients	Boston
Prapela, Inc.	Concord
Proof Diagnostics, Inc. (formerly Pine Trees Health, Inc.)	Cambridge
QSM Diagnostics, Inc.	Boston
Quanterix Corporation	Billerica
Reboot Rx	Winchester
Regenerative Bioelectronics, Inc.	Worcester
Reveal Pharmaceuticals, Inc.	Cambridge
Rubius Therapeutics	Cambridge
Sage Therapeutics, Inc.	Cambridge
Sanvita Medical Corporation	Billerica
Seaspire, Inc.	Cambridge
See Yourself Health, LLC	Beverly
Siemens Healthcare Diagnostics, Inc.	East Walpole
Snapdragon Chemistry	Waltham
Spero Therapeutics, Inc.	Cambridge
SQZ Biotech	Watertown
Stoke Therapeutics, Inc.	Bedford
Tekkware	Gloucester
TScan Therapeutics, Inc.	Waltham
Ultragenyx Pharmaceutical, Inc.	Cambridge
UrSure, Inc.	Allston
Versatope Therapeutics, Inc.	Lowell
Verve Therapeutics, Inc.	Boston
Vicarious Surgical, Inc.	Cambridge
WAVE Life Sciences	Cambridge
Wuxi Biologics USA, LLC	Cambridge
XGenomes Corp	Cambridge
Zoll Medical Corporation	Chelmsford

Fiscal Year 2021 Board Approved Angel Investor Tax Credit Recipients

Taxpayer Investor	Qualifying Business	Qualifying Business Location
J. Gentile	Anodyne Nanotech, Inc.	Medford
A. Epstein	Amsel Medical	Cambridge
B. Asefzadeh	Anodyne Nanotech, Inc.	Medford
B. Asefzadeh	Boston Cell Standards, Inc.	Boston
J. Gentile	Boston Cell Standards, Inc.	Boston
J. Markowitz	Boston Cell Standards, Inc.	Boston
K. Fan	Cellino Biotech, Inc.	Cambridge
K. Donovan	Concerto Biosciences, Inc.	Allston
G. Adaniya	Decoy Therapeutics, Inc.	Cambridge
G. O'Brien	DxLab, Inc.	Somerville
J. Malone III	DxLab, Inc.	Somerville
D. Poler	DxLab, Inc.	Somerville
W. Weddleton	Folia Health, Inc.	Cambridge
S. Haber	Hilltop BioSciences, Inc.	Mansfield
C. Rich	Hilltop BioSciences, Inc.	Mansfield
A. Zecha	Hilltop BioSciences, Inc.	Mansfield
J. Manaras	Hilltop BioSciences, Inc.	Mansfield
L. Cook	Intera Oncology, Inc.	Wellesley Hills
J. Davis	Intera Oncology, Inc.	Wellesley Hills
J. Reis	Intera Oncology, Inc.	Wellesley Hills
J. Deok Song	Intera Oncology, Inc.	Wellesley Hills
J. Baron	Intera Oncology, Inc.	Wellesley Hills
D. Dove	Intera Oncology, Inc.	Wellesley Hills
C. Bowen	KnipBio	Lowell
R. Harris	KnipBio	Lowell
R. Mui	KnipBio	Lowell
P. Doyle	Kytopen Corp.	Cambridge
J. Gentile	Kytopen Corp.	Cambridge
D. Finn	Gelmedix, Inc.	Newton
A. Krauss	Gelmedix, Inc.	Newton
M. Chester	LaunchPad Medical, Inc.	Lowell
K. Elsaid	LaunchPad Medical, Inc.	Lowell
A. Epstein	LaunchPad Medical, Inc.	Lowell
L. Nanberg	LaunchPad Medical, Inc.	Lowell
S. Nanberg	LaunchPad Medical, Inc.	Lowell
E. Klose	MindMics, Inc.	Cambridge
A. Sulkowski	MindMics, Inc.	Cambridge
G. O’Brien	MitoLab, Inc.	Allston
J. Malone III	MitoLab, Inc.	Allston
G. Mabry	New View Surgical, Inc.	Boston
B. Asefzadeh	QSM Diagnostics, Inc.	Boston
S. Gahan	QSM Diagnostics, Inc.	Boston
J. Gentile	QSM Diagnostics, Inc.	Boston
J. Markowitz	QSM Diagnostics, Inc.	Boston
R. Russell	QSM Diagnostics, Inc.	Boston
S. Tadikonda	QSM Diagnostics, Inc.	Boston
L. Derose	Regenerative Bioelectronics, Inc.	Worcester
M. Klitus	Regenerative Bioelectronics, Inc.	Worcester

Capital Awards from Inception through June 30, 2021

Program	Grantee	Infrastructure Related Project	Total Award	Year of Award	Status at End of FY 2021
Capital Program	Bay Path College	Planning Grant	$50,000	FY 2013	Completed
Capital Program	Bay Path University	Equipment for Workforce Training	$499,996	FY 2015	Completed
Capital Program	Baystate Health	Clinical Trials Unit	$3,949,912	FY 2019	Ongoing
Capital Program	BayState Medical Center	Health Informatics and Technology Innovation Center (HITIC)	$5,500,000	FY 2013	Completed
Capital Program	Berkshire Community College	Equipment for Workforce Training	$499,998	FY 2015	Completed
Capital Program	Berkshire Innovation Center	Life Sciences Incubator - Berkshire Innovation Center (BIC)	$11,970,000	FY 2018	Completed
Capital Program	Beth Israel Deaconess Medical Center	Organ on chip facility in a hospital setting	$1,705,471	FY 2020	Ongoing
Women's Health	Beth Israel Deaconess Medical Center	The Lactation Lab: Improving the health of two generations by optimizing breastfeeding	$857,563	FY 2020	Ongoing
Bits to Bytes	Beth Israel Deaconess Medical Center	Creating a Large Clinically Annotated Dataset of Antibody and TCR Repertoires in Cancer and Infectious Disease	$750,000	FY 2021	Ongoing
Women's Health Innovation	Beth Israel Deaconess Medical Center	Develop first in class agents that mitigate the underlying causes of preeclampsia	$110,000	FY 2021	Ongoing
Bits to Bytes	Beth Israel Deaconess Medical Center	Echocardiogram and electrocardiogram extension to the MIMIC database	$636,938	FY 2020	Ongoing
Capital Program	Beth Israel Deaconess Medical Center	Spatial Technologies Unit in the Precision Medicine Initiative at BIDMC	$3,307,757	FY 2021	Ongoing
Capital Program	BioBuilder	Learning Lab at LabCentral	$500,000	FY 2017	Ongoing
Bits to Bytes	Boston Children’s Hospital	Precision Nutrition for Term-born Infants	$749,950	FY 2021	Ongoing
Novel Therapeutics Delivery	Boston Children’s Hospital	Megakaryocyte-derived Extracellular Vesicles for Targeted Biotherapeutic Delivery to the Bone Marrow	$548,571	FY 2021	Ongoing
Capital Program	Boston Children's Hospital	Cell Therapy Center Improvements	$4,014,031	FY 2013	Completed
Capital Program	Boston Children's Hospital	Human Neuron Core Improvements	$2,263,133	FY 2015	Completed
Bits to Bytes	Boston Children's Hospital	Subcellular Dynamics	$658,167	FY 2019	Completed
Capital Program	Boston Children's Hospital	Center for Accelerated Therapeutic Development	$1,545,050	FY 2019	Ongoing
Women's Health Innovation	Boston Medical Center	Non-hormonal female contraceptive	$200,000	FY 2021	Ongoing
Novel Therapeutics Delivery	Boston University	Glycosylation analysis techniques and software to enable generation of more effective Influenza A virus vaccines	$749,349	FY 2020	Completed
Women's Health Innovation	Boston University	Development of novel breast cancer therapies by targeting epigenetic dysregulation in tumors	$200,000	FY 2021	Ongoing
Capital Program	Boston University	Business Innovation Center (BIC) at the BU Photonics Center	$363,750	FY 2015	Completed
Capital Program	Boston University	Biomedical Lab and Clinical Sciences Program	$180,000	FY 2015	Completed
Capital Program	Boston University Medical School	Center for Translational Neurotrauma Imaging	$4,896,000	FY 2019	Completed
Capital Program	Boston University Medical School	Lung Regeneration Initiative (LRI) Stem Cell Facility	$1,743,648	FY 2015	Completed
Capital Program	Brigham and Women’s Hospital	High Field Mass Spectometry	$5,000,000	FY 2019	Ongoing
Bits to Bytes	Brigham and Women's Hospital	Artificial Intelligence Guidance for High-Yield Point-of-Care Ultrasound Applications	$749,498	FY 2021	Ongoing
Capital Program	Brigham and Women's Hospital	Host-Microbiome Center	$2,603,537	FY 2015	Completed
Bits to Bytes	Brigham and Women's Hospital	Natural History of Neurofilament Concentrations and Mechanisms of Healthy Aging	$728,559	FY 2020	Ongoing
Women's Health	Brigham and Women's Hospital	The Lactation Lab: Improving the health of two generations by optimizing breastfeeding	$268,743	FY 2020	Ongoing
Bits to Bytes	Brigham and Women's Hospital	Serum miRNA	$750,000	FY 2019	Completed
Capital Program	Bristol Community College	Cleanroom-like suite educational space	$4,400,000	FY 2017	Completed
Bits to Bytes	Broad Institute	Cell Painting	$821,000	FY 2019	Completed
Bits to Bytes	Broad Institute	Data driven approaches to cardio diseases	$750,000	FY 2019	Ongoing
Capital Program	Bunker Hill Community College	Equipment for Workforce Training	$200,000	FY 2013	Completed
Capital Program	Cape Cod Community College	Equipment for Workforce Training	$394,912	FY 2014	Completed
Capital Program	City of Taunton	Development of Life Sciences Center in City of Taunton	$55,000	FY 2014	Completed
Capital Program	Dana-Farber Cancer Institute	Molecular Cancer Imaging Facility (MCIF)	$10,000,000	FY 2012	Completed
Capital Program	Dana-Farber Cancer Institute	Advanced Cell Therapy Unit at the Cell Manipulation Core Facility	$4,629,019	FY 2017	Completed
Capital Program	Dana-Farber Cancer Institute	Mass Spectrometry Metabolomics Solutions. Charting Metabolic Disease Development and Therapeutic Outcomes	$1,824,028	FY 2021	Ongoing
Women's Health	Dana-Farber Cancer Institute	Leveraging Digital Pathology to Identify and Cure High Risk Breast Cancer	$748,075	FY 2021	Ongoing
Women's Health Innovation	Dana-Farber Cancer Institute	Microdevice to measure drug response in ovarian cancer patients	$200,000	FY 2021	Ongoing
Women's Health Innovation	Dana-Farber Cancer Institute	Study of microbiome in relation to breast cancer and treatment options	$200,000	FY 2021	Ongoing
Capital Program	Dean College	Biology Laboratory Equipment	$297,030	FY 2017	Completed
Capital Program	Framingham State University	Science Center Laboratories Renovation	$454,000	FY 2017	Completed
Capital Program	Framingham State University	Hemenway Hall Science Center	$3,000,000	FY 2014	Completed
Capital Program	Framingham Wastewater and Pumping Station	Pleasant Street Water Transmission Line	$12,860,534	FY 2009	Completed
Capital Program	Gloucester Marine Genomics Institute	Marine Genomics Research Institute at Gloucester Harbor	$2,744,219	FY 2017	Completed
Capital Program	Gloucester Marine Genomics Institute	Cell Culture Lab	$174,383	FY 2019	Completed
Capital Program	Harvard Medical School	Laboratory of Systems Pharmacology expansion	$4,345,000	FY 2017	Completed
Bits to Bytes	Harvard Medical School	Metabolomics and Big Data	$750,000	FY 2019	Ongoing
Capital Program	Harvard Medical School	Laboratory Systems of Pharmacology (LSP)	$4,999,921	FY 2013	Completed
Women's Health	Harvard Medical School	Pathfinder: Studying Lymphocyte Repertoire Dynamics During Pregnancy in Autoimmune Sufferers	$750,000	FY 2021	Ongoing
Capital Program	Harvard School of Public Health	BioBank for Microbiome Research (BIOM-Mass)	$4,912,307	FY 2017	Completed
Bits to Bytes	Harvard School of Public Health	Microbiome in chronic disease management	$688,533	FY 2019	Completed
Novel Therapeutics Delivery	Harvard School of Public Health	Advancing CNS Therapeutic Delivery via ARMMs	$268,633	FY 2020	Ongoing
Bits to Bytes	Harvard School of Public Health	High Throughput Laboratory for Advanced Immunological Testing for Clinical and Public Health Surveillance	$737,950	FY 2021	Ongoing
Capital Program	Holyoke Community College	Center for Life Sciences	$3,800,000	FY 2013	Completed
Capital Program	Holyoke Community College	Equipment for Workforce Training	$300,000	FY 2015	Completed
Capital Program	Institute for Protein Innovation	Open-source Antibody Discovery platform	$5,000,000	FY 2017	Completed
Bits to Bytes	Institute for Protein Innovation	Solving the protein biologic developability problem with high-throughput laboratory science and machine learning	$750,000	FY 2021	Ongoing
Capital Program	Joslin Diabetes Center	Translational Center for the Cure of Diabetes	$5,000,000	FY 2012	Completed
Capital Program	Just-A-Start	Equipment	$46,079	FY 2014	Completed
Capital Program	Just-A-Start	Equipment	$49,992	FY 2015	Completed
Capital Program	Lab Central 238	Build-out facility to bridge gaps as startups design and test the processes prior to full-scale GMP production	$5,000,000	FY 2019	Completed
Capital Program	LabCentral	Accelerator Lab	$4,955,515	FY 2013	Completed
Capital Program	LabCentral	Accelerator Lab Expansion	$5,000,000	FY 2014	Completed
Capital Program	MA Green High Performance Computing Center	Commonwealth Computational Cloud for Data Driven Biology Facility (C3DDB)	$4,540,000	FY 2013	Completed
Capital Program	Marine Biological Laboratory in Woods Hole	Center for Regenerative Biology and Medicine	$10,000,000	FY 2009	Completed
Capital Program	Massachusetts Biomedical Initiatives	Expanding the Central MA Biomedical Infrastructure to Grow the Regional Cluster	$3,494,256	FY 2019	Completed
Capital Program	Massachusetts Biomedical Initiatives	Expansion of Incubator Space	$500,000	FY 2020	Completed
Capital Program	Massachusetts General Hospital	Transforming Clinical Research for Brain Health	$4,805,000	FY 2019	Completed
Bits to Bytes	Massachusetts General Hospital	An integrative platform to understand and exploit cancer metabolism	$750,000	FY 2020	Completed
Novel Therapeutics Delivery	Massachusetts General Hospital	Advancing CNS Therapeutic Delivery via ARMMs	$481,367	FY 2020	Ongoing
Novel Therapeutics Delivery	Massachusetts General Hospital	High resolution pharmacokinetics: imaging drug delivery from administration to on-target activity (high-res PK DATA)	$749,998	FY 2020	Completed
Women's Health Innovation	Massachusetts General Hospital	Treatment of autoimmune conditions through CAR-T cells	$200,000	FY 2021	Ongoing
Women's Health Innovation	Massachusetts General Hospital	Single-cell and multiomic approach to molecular and cellular ecosystem to understand women’s health conditions	$197,993	FY 2021	Ongoing
Bits to Bytes	Massachusetts General Hospital	Facilitating drug development for neurodegenerative diseases	$666,500	FY 2020	Ongoing
Bits to Bytes	Massachusetts Institute of Technology	Echocardiogram and electrocardiogram extension to the MIMIC database	$358,918	FY 2020	Ongoing
Novel Therapeutics Delivery	Massachusetts Institute of Technology	Regioselective conjugation of peptides to the major histocompatibility complex I (MHC I)	$747,427	FY 2020	Completed
Capital Program	Massachusetts Institute of Technology	Technology Platform for Brain Research	$1,838,000	FY 2015	Completed
NIIMBL	Massachusetts Institute of Technology	Blended Learning Cell Therapy Course	$330,200	FY 2018	Completed
Building Breakthroughs	Massachusetts Institute of Technology	Continuous Countercurrent Tangential Chromatography (CCTC)	$750,000	FY 2019	Ongoing
Building Breakthroughs	Massachusetts Institute of Technology	Model Predictive Control for Improved Product Quality in the Production of Viral Vectors-	$732,674	FY 2019	Completed
NIIMBL	Massachusetts Institute of Technology	Small-scale Membrane-less Perfusion Bioreactor System	$267,182	FY 2019	Completed
NIIMBL	Massachusetts Institute of Technology	Viral Vaccines	$225,612	FY 2019	Completed
NIIMBL	Massachusetts Institute of Technology	Modularized PAT Online Training Platform to Accelerate the Workforce Innovation in Biopharmaceuticals Manufacturing	$266,850	FY 2021	Ongoing
Women's Health	Massachusetts Institute of Technology	Nerve-immune Interactions as A Target of Endometriosis and Adenomyosis therapies	$665,000	FY 2021	Ongoing
Women's Health Innovation	Massachusetts Institute of Technology	Increasing access to egg freezing through automation	$195,621	FY 2021	Ongoing
Capital Program	MassBay Community College	Therapeutics and Genomics Training	$500,000	FY 2019	Ongoing
Capital Program	MassBay Community College	Planning Grant	$43,920	FY 2014	Completed
NIIMBL	MassBiologics	Improve Lentiviral Vector Biomanufacturing for Cell and Gene Therapy Applications	$447,566	FY 2018	Completed
NIIMBL	MassBiologics	Viral Vaccines	$185,540	FY 2019	Completed
Capital Program	MassBiologics-UMass Medical School	Vector Manufacturing Center (VMC) in Mattapan Facility	$5,000,000	FY 2014	Completed
Capital Program	Merrimack College	Interdisciplinary Imaging and Analytical Science Equipment	$500,000	FY 2017	Completed
Capital Program	Middlesex Community College	Planning Grant	$36,664	FY 2013	Completed
Capital Program	Middlesex Community College	Biotechnology Training Facility	$3,000,000	FY 2014	Completed
Capital Program	Mount Wachusett Community College	Equipment for Workforce Training	$499,146	FY 2014	Completed
Capital Program	Mt. Wachusett Community College	Medical laboratory technology classroom	$1,646,725	FY 2017	Completed
Capital Program	Museum of Science	Hall of Human Life Exhibit	$5,000,000	FY 2012	Completed
Capital Program	Museum of Science	Race to the Vaccine Exhibition	$1,520,760	FY 2021	Ongoing
Capital Program	New Bedford Economic Development Council	Regional Incubation Center for Life Science Initiatives	$75,000	FY 2014	Completed
Capital Program	North Shore Biotech Consortium	Life Sciences Consortium of the North Shore	$5,000,000	FY 2014	Completed
Capital Program	North Shore InnoVentures	NSIV Expansion	$1,500,000	FY 2019	Completed
Capital Program	Northeastern University	Biopharma Analysis Training Lab	$4,271,867	FY 2019	Ongoing
NIIMBL	Northeastern University	Modularized PAT Online Training Platform to Accelerate the Workforce Innovation in Biopharmaceuticals Manufacturing	$375,000	FY 2021	Ongoing
Novel Therapeutics Delivery	Northeastern University	CNS Delivery of Nucleic Acid Therapeutics using MIND	$749,858	FY 2021	Ongoing
Bits to Bytes	Northeastern University	In Silico design of an arrary chromophores	$750,000	FY 2019	Ongoing
Capital Program	Northern Essex Community College	Haverhill and Lawrence Labs	$1,242,000	FY 2013	Completed
Capital Program	Pittsfield Economic Development Authority	Planning Grant	$55,000	FY 2013	Completed
Capital Program	Quincy College	Workforce Training in Biomanufacturing: Upstream & Downstream Processing	$725,739	FY 2019	Ongoing
NIIMBL	Quincy College	Equipment and supplies needed to support new gene and cell therapy training.	$50,000	FY 2020	Ongoing
Capital Program	Quincy College	Equipment for Workforce Training	$78,799	FY 2013	Completed
Capital Program	Quincy College	Equipment for Workforce Training	$499,872	FY 2014	Completed
Capital Program	Quinsigamond Community College	Equipment for Workforce Training	$310,000	FY 2013	Completed
Capital Program	Quinsigamond Community College	Equipment for Workforce Training	$499,880	FY 2014	Completed
Capital Program	Quinsigamond Community College	Capital and Equipment	$4,999,998	FY 2015	Completed
Capital Program	Regis College	Planning Grant	$50,000	FY 2013	Completed
Capital Program	Regis College	Equipment for Workforce Training	$355,000	FY 2015	Completed
Capital Program	Roxbury Community College	Capital and Equipment	$3,000,000	FY 2015	Completed
Capital Program	Smith College	Equipment - Center for Molecular Biology, Microscopy & Imaging	$489,435	FY 2017	Completed
Capital Program	Springfield Technical Community College	Planning Grant	$85,673	FY 2013	Completed
Capital Program	Springfield Technical Community College	Biomedical Engineering Lab	$972,850	FY 2015	Completed
Capital Program	The Forsyth Institute	Forsyth Center for Salivary Diagnostics (FCSD)	$4,133,215	FY 2013	Completed
Capital Program	The Forsyth Institute	Host Microbiome Center	$2,210,229	FY 2015	Completed
Capital Program	The Mansfield Bio-Incubator	Bio-incubator Laboratory infrastructure expansion project	$2,000,000	FY 2020	Ongoing
Bits to Bytes	Tufts University	Noninvasive detection of bladder cancer through advanced nanoscale imaging and machine learning analysis	$750,000	FY 2021	Ongoing
Novel Therapeutics Delivery	Tufts University	Transdermal delivery of monoclonal antibody therapy using macro-porous structured hard microneedle technology	$745,403	FY 2021	Ongoing
Capital Program	Tufts University	Establishing a state of the art comparative infectious disease pathology core to accelerate translational research	$2,027,244	FY 2021	Completed
Women's Health	Tufts University	Elucidating sex differences in network aberrations in depression while building equitable infrastructure for research	$251,548	FY 2021	Ongoing
Capital Program	Tufts/Cummings School of Veterinary Medicine	School of Veterinary Medicine (NE-RBL)	$9,500,000	FY 2009	Completed
Capital Program	UMass Amherst	MLSC Open Capital Flow Cytometry at UMass Amherst	$1,101,559	FY 2020	Ongoing
Capital Program	UMass Amherst	Enhancement of the UMass Amherst Light Microscopy Facility for cutting edge	$515,617	FY 2020	Completed
Capital Program	UMass Amherst	Acquisition of Synapt G2-32k Mass Spectrometer for biopharmaceutical	$299,329	FY 2020	Completed
Capital Program	UMass Amherst	SampleJet, high throughput sample changing roboto for NMR	$129,900	FY 2020	Completed
Women's Health	UMass Amherst	Artificial Intelligence for Menopause Symptoms (AIMS)	$747,225	FY 2020	Ongoing
Capital Program	UMass Amherst	Life Sciences Laboratory Research Center Complex	$95,000,000	FY 2013	Completed
Women's Health Innovation	UMass Amherst	Thermal therapeutic to regulate sleeping in menopausal women	$199,911	FY 2021	Ongoing
Bits to Bytes	UMass Boston	The Oregon-Massachusetts Mammography Database (OMAMA-DB)	$749,834	FY 2020	Ongoing
Capital Program	UMass Boston	Conversion of Venture Development Center (VDC)	$588,848	FY 2014	Completed
Capital Program	UMass Boston	Center for Personalized Cancer Therapy (CPCT)	$9,878,503	FY2011/ FY2014	Completed
Capital Program	UMass Boston	NextGen Sequencing at the Next Level: UMass Boston CPCT Genomic Core	$388,324	FY 2020	Ongoing
Capital Program	UMass Dartmouth	Massachusetts Accelerator for Biomanufacturing (MAB)	$20,600,000	FY 2012	Completed
Capital Program	UMass Dartmouth	Advanced Technology Manufacturing Center (ATMC)	$11,400,000	FY 2012	Completed
Capital Program	UMass Lowell	Perry Hall build out for BME Program Laboratories	$5,000,000	FY 2017	Completed
NIIMBL	UMass Lowell	Bioreactor Trace Meal Quantification	$246,754	FY 2018	Completed
NIIMBL	UMass Lowell	Lyophilization Scale-up	$1,000,000	FY 2018	Completed
Building Breakthroughs	UMass Lowell	Integrated Continuous Biopharma Manufacturing	$746,118	FY 2019	Ongoing
NIIMBL	UMass Lowell	Lyophilization Scale-up (Additional funding)	$299,779	FY 2019	Completed
NIIMBL	UMass Lowell	Developing a Fluorescence-based Multi-step IEX-HPLC Method for Quantification of Capsid in AAV products	$216,090	FY 2021	Ongoing
Capital Program	UMass Lowell	Emerging Technologies and Innovation Center (ETIC)	$10,000,000	FY 2012	Completed
Capital Program	UMass Lowell	Big Company/Little Company (M2D2 Innovation Hub)	$5,046,592	FY 2014	Completed
Capital Program	UMass Lowell	Establishing a public small animal imaging core research facility for Northeast Massachusetts	$1,132,949	FY 2020	Completed
Women's Health	UMass Lowell	Breast Cancer Detection Empowered by Contrast Agents, Spectral CT, and Machine Learning	$591,000	FY 2020	Ongoing
Bits to Bytes	UMass Chan Medical School	AI in high resolution neurovascular imaging	$750,000	FY 2019	Ongoing
Women's Health	UMass Chan Medical School	Breast Cancer Detection Empowered by Contrast Agents, Spectral CT, and Machine Learning	$159,000	FY 2020	Ongoing
Capital Program	UMass Chan Medical School	Titan Krios Microscope for the MACryoEM	$5,000,000	FY 2015	Completed
Bits to Bytes	UMass Chan Medical School	Spatial transcriptomic approaches to map neuroinflammation in neurodegenerative disease	$750,000	FY 2020	Ongoing
Capital Program	UMass Chan Medical School	UMass Chan Medical School Positron Emission Tomography Center	$1,370,315	FY 2020	Completed
Capital Program	UMass Chan Medical School	Enhancing Innovation in Drug Discovery at UMass Chan Medical School	$926,305	FY 2020	Completed
Women's Health	UMass Chan Medical School	Improving Breast Cancer Diagnosis Using Artificial Intelligence in Mammography Screenings	$750,000	FY 2020	Ongoing
Capital Program	UMass Chan Medical School	Massachusetts Center for High-Resolution Electron Cryomicroscopy	$2,797,610	FY 2021	Completed
Capital Program	UMass Chan Medical School	Albert Sherman Center	$90,000,000	FY 2010	Completed
Capital Program	Venture Cafe	Capital Improvements to District Hall	$347,000	FY 2014	Completed
Capital Program	Wellesley College	Planning Grant - Renovation of Life Sciences Center	$49,376	FY 2015	Completed
Capital Program	Western New England University	Equipment for Workforce Training	$497,449	FY 2014	Completed
Capital Program	Westfield State University	Planning Grant - Center for Biotechnology at WSU	$43,564	FY 2017	Completed
Women's Health	Westfield State University	Predictive modeling to create "bioprofiles": for use in personalized medicine in women's health	$750,000	FY 2020	Ongoing
Building Breakthroughs	Worcester Polytechnic Institute	Recombinant Adeno-Associated Virus	$566,815	FY 2019	Completed
Capital Program	Worcester Polytechnic Institute	Cell Engineering Research Accelerator @ WPI	$877,314	FY 2020	Completed
Women's Health Innovation	Worcester Polytechnic Institute	Increase understanding of maternal-fetal interface through lipid-based models	$137,542	FY 2021	Ongoing
Capital Program	Worcester Polytechnic Institute	Biomanufacturing Education and Training Center (BETC)	$5,149,999	FY 2010	Completed
NIIMBL	Worcester Polytechnic Institute	Blended Learning Cell Therapy Course	$262,267	FY 2018	Completed
NIIMBL	Worcester Polytechnic Institute	SPIDER Project	$139,984	FY 2018	Completed
Novel Therapeutics Delivery	Wyss Institute at Harvard	New targets and novel antibody shuttles for brain delivery of therapeutics	$750,000	FY 2020	Ongoing
		Total	$526,505,152

College and High School Internship Program Diversity Statistics

1. Total funds expended on high school internships	$40,016.53
2. Total funds expended on college internships	$2,918,135.63
3. Number of students participating in the internship programs from each high school, school district, college and university in the Commonwealth:	Provided in Annual Report Appendix
4. Percentage of high school internships awarded to minority students attending schools where at least 80% of the student population is eligible for free or reduced lunch:	11 out of 24 (46%) identified as a race other than Caucasian, but non of which attended economically disadvantaged* schools.
5. Percentage of college internships awarded to minority students enrolled full-time or part-time at a community college:	5 (1%) interns out of 368 respondents were enrolled in a community college and identified as a race other than Caucasian.
6a. Racial and ethnic composition of the high school internship program:	Asian: 7 (29%) Caucasian: 13 (54%) Latinx: 2 (8%) Multi-Racial/Other: 2 (8%)
6b. Racial and ethnic composition of the college internship program:	Asian: 97 (26%) Black: 18 (5%) Caucasian: 22 (61%) Latinx: 17 (15%) Native American: 1 Multi-Racial/Other: 9 (2%)
7. Analysis of the impact of the college internship program on the ability of its participants to enter the full-time job market in the life science industries after graduation:	For the 2020-2021 Program Year, 39 interns that graduated in 2019-2021 were reported to have been hired for full-time positions by the company that hosted them.

Internship Host Organizations

Company/Institution	Location
Abpro Labs	Woburn
Abveris Antibody	Canton
Access Vascular, Inc.	Woburn
Adaptive Surface Technologies Inc.	Cambridge
Addgene, Inc.	Cambridge
Adeptrix Corp	Beverly
AdMeTech Foundation	Boston
Admetsys Corporation	Boston
Advanced Continuing Education Association	Boston
Advanced Research and Development	North Andover
Advanced Silicon Group	Lincoln
Alira Health Boston LLC	Framingham
Alkeus Pharmaceuticals, Inc.	Somerville
Allurion Technologies	Natick
AltrixBio Inc.	Cambridge
AlvaMed, Inc.	Needham
Amplyus	Cambridge
Angiex	Cambridge
Anodyne Nanotech, Inc.	Boston
Antagen Pharmaceuticals, Inc	Boston
Aphios Corporation	Woburn
Applied Pathology Systems	Shrewsbury
Arsenal Medical	Watertown
Arteriocyte Medical Systems DBA Isto Biologics	Hopkinton
Atantares Corp	Cambridge
Avania LLC	Marlborough
Avastus Preclinical Services	Cambridge
Averica Discovery Services, Inc.	Marlborough
Aveta Biomics, Inc.	Bedford
Axonis Therapeutics, Inc.	Cambridge
Barrett Technology, Inc.	Newton
Bayard Design, LLC	Cambridge
Beacon Biosignals, Inc.	Boston
Beantown Biotech, LLC	Natick
Behavioral Health Innovators, Inc.	S. Chatham
Biobot Analytics	Somerville
Bio-Detail Corporation	Worcester
BioSensics LLC	Cambridge
BioSurfaces, Inc.	Ashland
Bitome, Inc.	Boston
Blackstone Valley Engineering and Technical Services LLC	Marlborough
Boston Bioskills Lab	Boston
Boston Children's Hospital	Boston
Boston Innovation Technology	Waltham
Boston Institute of Biotechnology LLC	Southborough
Boston MedTech Advisors	Dedham
Boyd Technologies	Lee
BrainSpec	Boston
Brigham and Women's Hospital	Boston
Brixton Biosciences	Cambridge
Broad Institute	Cambridge
Cam Med LLC	Newton
Cambridge Scientific Products	Watertown
Caraway Therapeutics, Inc.	Cambridge
Carefree Pharmacy	Andover
CatAilyst inc.	Needham
CDX Analytics, LLC	Salem
Cellaria Biosciences	Cambridge
Celldex Therapeutics, Inc.	Needham
Celsius Therapeutics	Cambridge
Centaur Diagnostics, Inc.	Boston
CF Technologies, Inc.	Boston
Coatings2Go	Carlisle
Codiak Biosciences, Inc.	Cambridge
Cognito Therapeutics	Cambridge
Concerto Biosciences	Boston
Convergent Dental	Natick
Corvia Medical	Tewksbury
CovalX	Saugus
Covaris, Inc.	Woburn
CreaGen Biosciences, Inc.	Woburn
Cure Rare Disease	Cambridge
CuriRx, Inc.	Wilmington
CYTO Consulting	Lexington
Datycs, Inc.	Methuen
Day Zero Diagnostics, Inc.	Boston
Decibel Therapeutics, Inc.	Boston
Delsys, Inc.	Natick
Delve, Inc.	Boston
DentalTOR, Inc.	Boston
Dermal Photonics Corporation	Middleton
Diagnostic Equipment Service Corporation	Belchertown
DNA Medicine Institute	Cambridge
DRF Engineering Services, LLC	Framingham
Dyno Therpapeutics, Inc	Cambridge
E-Green LLC	Boston
Elektrofi Inc.	Cambridge
Elpis Biopharmaceuticals	Lexington
Elucid Bioimaging, Inc.	Boston
EMBR Labs, Inc.	Cambridge
Empatica, Inc.	Cambridge
Enable Life Sciences LLC	Worcester
EndoSim, LLC	Bolton
EpigenDx, Inc.	Hopkinton
Erbi Biosystems, Inc.	Woburn
Eutropics Pharmaceuticals	Cambridge
Excellims Corporation	Acton
Fikst, LLC	Woburn
First Light Biosciences	Bedford
Flexomics LLC	Boston
FluidForm, Inc.	Acton
Fluigent, Inc.	Lowell
Folia Materials	Amherst
Founders Science Group	Taunton
Fractyl Laboratories, Inc.	Waltham
Gel4Med	Boston
Genocea Biosciences, Inc.	Cambridge
Genomic Expression Inc.	Beverly
Genoskin Inc.	Boston
Gentuity, LLC	Sudbury
Giner Life Sciences, Inc.	Newton
Giner, Inc.	Newton
Glyscend, Inc.	Lowell
GO Therapeutics	Cambridge
HealthBeacon	Boston
HelixBind, Inc.	Marlborough
Hemedex Inc.	Cambridge
HiFiBiO, Inc.	Cambridge
Holobiome	Cambridge
Human Systems Integration	Walpole
Hyalex Orthopaedics, Inc.	Lexington
Hybrigenics Corporation	Cambridge
Ichosia Biotechnology	Worcester
iHope Network	Beverly
Imagine Optic, Inc.	Boston
InCrowd, Inc.	Boston
Initium Therapeutics Inc	Natick
Integral BioSystems, LLC	Bedford
Interscope, Inc.	Whitinsville
iOmics Corporation	Cambridge
iSpecimen, Inc.	Lexington
J&J Machine Company, Inc.	Marlborough
Jana Care	Boston
Jura Bio, Inc.	Worcester
Kephera Diagnostics, LLC	Framingham
Kernal Biologics, Inc.	Cambridge
L.E.A.F. Pharmaceuticals	Woburn
LabShares Newton, LLC	Newton
LakePharma	Worcester
LaVoie Health Sciences	Boston
Leading Business Ventures, LLC	Cambridge
Leuko Labs, Inc.	Boston
Leveragen, Inc.	Worcester
LexaGene	Beverly
Lexington Medical, Inc.	North Billerica
Life Science Cares	Cambridge
Life Science Nation	Boston
LifeMine Therapeutics	Cambridge
Liquiglide, Inc.	Cambridge
Lucy Therapeutics, Inc.	Cambridge
Lykan Bioscience, LLC	Hopkinton
Manus Biosynthesis, Inc.	Cambridge
Marvelbiome, Inc.	Woburn
Mass General Hospital	Boston
MedChem Partners LLC	Lexington
Mediate	Somerville
MedicaMetrix, Inc.	Lowell
Medicinal Genomics Corporation	Woburn
MedPanel	Cambridge
Microgradient Fluidics LLC	Worcester
Micro-Leads, Inc.	Boston
MobiDrop, Inc.	Cambridge
Morphic Therapeutic Inc	Waltham
Mouse Specifics, Inc.	Framingham
Myomo, Inc.	Cambridge
Mytide Therapeutics, Inc.	Boston
NanoView Biosciences, Inc.	Boston
NEHI, Inc.	Cambridge
NeuroScouting LLC	Cambridge
New Equilibrium Biosciences, Inc.	Boston
Nix, Inc.	Cambridge
North East Biomedical, Inc.	Tyngsborough
Novabioassays, LLC	Woburn
Nuclease Probe Technologies	Belmont
Octagon Therapeutics	Boston
Ocular Technologies Inc.	Boston
Omega Therapeutics Inc.	Cambridge
OPT Industries, Inc.	Cambridge
Partner Therapeutics	Lexington
Perthera, Inc.	Holliston
PhAST Corp.	Boston
Phoenix Tailings	Woburn
Phosphorex, Inc.	Hopkinton
Pinetree Therapeutics, Inc.	Andover
Platelet Biogenesis	Boston
Podimetrics, Inc.	Somerville
Pop Up Labs (dba MakerHealth)	Boston
Portal Instruments, Inc.	Cambridge
Power of Patients	Boston
PraNA Biosciences LLC	Worcester
Precision Fabricators Ltd.	Stoughton
Pressure BioSciences, Inc.	South Easton
Prime Bio, Inc.	Dartmouth
Privo Technologies	Peabody
Prospective Research, Inc.	Beverly
Protom International Holding Corporation	Wakefield
Pulsar Bio Inc.	Cambridge
Pykus Therapeutics	Cambridge
RAN Biotechnologies, Inc.	Beverly
Ras Labs, LLC	Quincy
RedShift BioAnalytics, Inc.	Burlington
Regenerative Bioelectronics Inc.	Worcester
Reprieve Cardiovascular	Milford
Respiratory Motion, Inc	Waltham
ReSurfX LLC	Lexington
Ring Therapeutics, Inc.	Cambridge
S2N Health, LLC	Boston
SafePath Medical, Inc	Amesbury
Sage Science, Inc.	Beverly
Scimpact, LLC	Cambridge
See Yourself Health	Beverly
Seeding Labs	Boston
SeLux Diagnostics	Boston
SemiNex Corporation	Peabody
Shepherd Therapeutics, LLC	Boston
Snapdragon Chemistry, Inc.	Cambridge
Solarea Bio, inc.	Cambridge
Sophion Bioscience Inc	Woburn
SpadXTech	Worcester
Spatio Metrics	Cambridge
Spectrus LLC	Beverly
Spero Therapeutics, Inc.	Cambridge
Stability Health, LLC	Worcester
STAR Analytical Services	Bedford
STC Biologics, Inc.	Cambridge
StemCellerant, LLC	Boston
Strand Therapeutics	Cambridge
Symmetric Computing, Inc.	Boston
Tarveda Therapeutics	Watertown
Tepha	Lexington
TFC Biosciences,Inc.	Norwood
The Learning Corp.	Lexington
Thermedical, Inc.	Waltham
Tiba Biotech LLC	Cambridge
Tidal Therapeutics, Inc.	Cambridge
Toothprints PC	Hopkinton
Union Biometrica, Inc.	Holliston
UptimeHealth, Inc.	Boston
Vaxess Technologies, Inc.	Cambridge
Versatope Therapeutics, Inc.	Lowell
VideaHealth	Boston
VisionCare- IMMAD	Quincy
Vivonics, Inc	Sudbury
Vivtex Corporation	Cambridge
VocaliD, Inc.	Belmont
Vox Biomedical LLC.	Newton
Vulcan Biologics	Cambridge
WellNested (FKA CaroCare)	Boston
Woodland Biosciences	North Grafton
X4 Pharmaceuticals, Inc.	Cambridge
X-CHEM, Inc.	Waltham
X-COR Therapeutics	Framingham
Xeno Therapeutics, Inc.	Boston
Yurogen Biosystems	Worcester
Zaiput Flow Technologies	Cambridge
ZATA Pharmaceuticals, Inc.	Worcester
ZebiAI Therapeutics, Inc.	Waltham

High School Interns by School and District

High School / School District	Interns
Acton-Boxborough Regional High School	1
Al Noor Academy	2
Algonquin Regional High School	2
Amherst Regional High School	2
Ashland High School	1
Bancroft School	1
Blue Hills Regional Technical School	1
Boston College High School	1
Chelmsford High School	1
Deerfield Academy	1
Hingham High School	1
Lexington High School	2
Lincoln Sudbury Regional High School	2
Newton North High School	1
Nipmuc Regional High School	1
Plymouth North High School	1
Saint Joseph Preparatory High School	1
Sharon High School	1
Weston High School	1

School District
Acton-Boxborough Regional School District	1
Amherst Public Schools	2
Ashland Public Schools	1
Blue Hills Regional School District	1
Chelmsford Public Schools	1
Hingham Public Schools	1
Lexington Public Schools	2
Lincoln-Sudbury Regional School District	2
Mendon-Upton Regional School District	1
Newton Public Schools	1
Northborough-Southborough Regional School District	2
Plymouth Public Schools	1
Sharon Public Schools	1
Weston Public Schools	1

College Interns by Academic Institution

College/University	Interns
Assumption College	1
Babson College	2
Bentley University	1
Boston College	7
Boston University	29
Brandeis University	8
Bridgewater State University	2
Bristol Community College	3
Brown University, RI	5
Bucknell University, PA	2
Bunker Hill Community College	4
Carnegie Mellon University, PA	1
College of the Holy Cross	1
Dartmouth College, NH	2
Dickinson College, PA	1
Drexel University, PA	1
Emmanuel College	2
Endicott College	4
Framingham State University	3
Franklin W. Olin College of Engineering	4
Gloucester Biotechnology Academy	8
Gordon College	2
Harvard University	15
Ithaca College, NY	1
Johns Hopkins University, MD	2
Keene State College, NH	1
Lehigh University, PA	1
Massachusetts Bay Community College	4
Massachusetts College of Art	1
Massachusetts College of Pharmacy and Health Sciences University (MCPHS University)	3
Massachusetts Institute of Technology	12
Merrimack College	2
Middlebury College, VT	1
Middlesex Community College	3
Nashua Community College	1
Northeastern University	81
Northern Essex Community College	2
Quincy College	5
Quinnipiac University, CT	2
Quinsigamond Community College	3
Rensselaer Polytechnic Institute, NY	3
Rochester Institute of Technology, NY	3
Roxbury Community College	1
Salem State University	2
Skidmore College	2
Smith College	1
Stonehill College	2
Stony Brook University, NY	1
Suffolk University	2
Syracuse University, NY	1
Tufts University	17
University of Connecticut	3
University of Massachusetts Amherst	27
University of Massachusetts Boston	5
University of Massachusetts Dartmouth	2
University of Massachusetts Lowell	23
University of Miami	1
University of Michigan	2
University of New Hampshire	1
University of Pittsburgh	1
University of Rhode Island	4
University of Southern California	1
University of Wisconsin	1
Virginia Polytechnic Institute and State University	1
Wellesley College	1
Wentworth Institute of Technology	5
Wesleyan University, CT	1
Western New England University	1
Wheaton College	3
Williams College	1
Worcester Polytechnic Institute	27
Worcester State University	2

COVID-19 Programs

Grantee	Program	Title	Total
Advanced Functional Fabrics of America, Inc.	M-ERT	Stand up and sustain a regional testing for PPE products to validate foreign purchases before distributed to emergency workers	$ 237,764.00
Avila Textiles, Inc.	M-ERT	Production of face masks via woven-webbing technique	$ 85,756.00
Blackstone Valley Machining	M-ERT	Machining parts for ventilators	$ 55,000.00
Boston Engineering Corporation	M-ERT	Provision rapidly deployed capacity of skilled staff to assist with medical ventilator supply and innovation	$ 160,000.00
CareAline Products, Inc.	M-ERT	Manufacturing reusable Level 1 isolation gowns; materials for sewing and staff hires	$ 101,250.00
Cogmedix, Inc.	M-ERT	Implement 3 FDA-compliant manufacturing lines in a ISO13485 facility	$ 390,593.00
Contollo Mass Manufacturing, LLC	M-ERT	Facility prep to pivot to material for gowns, training, and Quality Management System	$ 1,840,000.00
FormLabs, Inc.	M-ERT	Establish 3D-printed Nasopharyngeal Swab manufacturing facility in MA	$ 465,050.00
Heritage Hemp, LLC	M-ERT	Production of hand sanitizer	$ 63,352.17
High Purity Natural Products, LLC	M-ERT	Production of hand sanitizer	$ 52,500.00
Industrial Polymers and Chemicals, Inc.	M-ERT	Production of vital PPE isolation gowns	$ 150,000.00
International Light Technologies	M-ERT	Construction of additional manufacturing work station, which produces a critical component in 7500 Fast Dx Real-Time PCR instrument	$ 16,138.00
MatTek Corporation	M-ERT	Production of viral transfer media	$ 40,000.00
Massachusetts Institute of Technology	M-ERT	Testing and diagnosis of filtration efficiency struture for material samples provided by healthcare workers	$ 142,224.00
Precision Sportswear, Inc.	M-ERT	Production of medical products like masks and gowns	$ 32,755.00
Tekkware, Inc.	M-ERT	Pivot manufacturing operations into hand sanitizer and scale up production	$ 209,840.00
Transcom Scopes, Inc.	M-ERT	Purchase of additional tooling and fixtures to assist with output on machined ventilator parts	$ 41,283.00
Umbulizer	M-ERT	Manufacture FDA-approved low-cost ventilator	$ 99,494.00
Vecna Technologies, Inc.	M-ERT	Provide MA with emergency ventilation capacity at low cost/subsidized cost based on MIT E-Vent	$ 253,900.00
Web Industries, Inc.	M-ERT	Rapid diagnostic test manufacturing	$ 2,563,103.00
Boston Children's Hospital	MassCPR	Rapid Point of Care Diagnostics using DNA Nanoswitches	$ 300,000.00
Boston Children's Hospital	MassCPR	COVID-19 surveillance and modeling platform development	$ 220,000.00
Boston University	MassCPR	Large scale, cost-efficient screening and detection of SARS-CoV-2 in underserved population	$ 300,000.00
Brigham and Women's Hospital	MassCPR	Readily deployable ventilator splitters to accommodate COVID-19 patient surges	$ 268,241.00
Harvard School of Public Health	MassCPR	Update to the HGHI CoVID-19 US Hospital Capacity Model: ICU Surge, Post Acute Care Beds, Survey of Mechanical Ventilator Supply	$ 346,719.00
Massachusetts Institute of Technology	MassCPR	A Simple and Direct Antigen Rapid Test for SARS-CoV-2 Infections: Ready for Scale-Up	$ 300,000.00
Tufts University, Boston University, Beth Israel Deaconess Medical Center	MassCPR	Support for Clinical Specimen Procurement at additional hospitals	$ 600,000.00
Amplyus, LLC	ACTS	Portable point of need devices for inexpensive detection of SARS-CoV-2 using LAMP molecular assays	$ 150,879.00
Antagen Diagnostics, Inc.	ACTS	Rapid POC Test for COVID-19 Neturalizing Antibodies to ID vaccine non-responders and other vulnerable population for better protection	$ 178,665.00
Beth Israel Deaconess Medical Center	ACTS	Clinical performance and appropriate use of SARS-CoV-2 antigen tests in healthcare settings	$ 230,652.68
Brigham and Women's Hospital	ACTS	Systematic evaluation of the acuracy of rapid antigen tests for diagnosis of asymptomatic SARS-CoV2 carriers	$ 404,035.00
Kephera Diagnostics, LLC	ACTS	Rapid antigen test for point-of-care testing modalities	$ 417,074.00
Virex Health, Inc.	ACTS	Virometer and virus strips for SARS-CoV-2 diagnosis	$ 510,000.00
		Total Awards	$ 11,226,267.85